Development Of HIV-1 Vaccine

by Rukmani Krishna on  November 15, 2012 at 11:39 PM AIDS/HIV News   - G J E 4
HIV-1 is a genetically diverse collection of viruses. This makes it a moving target in vaccine development.
 Development Of HIV-1 Vaccine
Development Of HIV-1 Vaccine

In a study published in the Journal of Clinical Investigation, researchers led by Brad Jones at the University of Toronto in investigated the feasibility of eliminating HIV-infected cells by targeting cellular immune responses against a human endogenous retrovirus (HERV). HERVs are the DNA remnants of ancient infectious retroviruses that became part of the germ line cells of our ancestors.

Jones and colleagues found that HIV infection stimulated the expression of HERV proteins, effectively tagging HIV-infected cells. Immune cells targeted to these proteins specifically eliminated cells infected with several different strains of HIV in vitro. This study suggests that HERV-targeted immune responses should be considered in the development of HIV vaccines.TITLE:
HERV-K-targeted T-cells eliminate diverse HIV-1/2 and SIV primary isolatesAUTHOR CONTACT:
Brad Jones
University of Toronto, Toronto, ON, CAN
Phone: 617-777-9151; E-mail:

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

More News on: